A study from our team has investigated the impact of a decorin treatment on human Beta cells from healthy and T2D donors and have concluded an increase in glucose-stimulated insulin secretion in Beta cells isolated from T2D donors associated with an increase in insulin content [145]. This evidence concerns the gene DCN and type 2 diabetes mellitus.